# Agent C, final pass on v4

## 1. Does v4 pass the challenge?

- **N1–N7.** The storyline passes. Two exceptions:
  - Title 1 uses "reusable", and the Question opens with it. That is a replicability claim that has not been evidenced yet (v4's own §5.8).
  - P3 says "report useful flags", which is the kind of word N2 bars.
- **Brackets.** [N] is a count from the pipeline. [n], [1/p] and [k₂] require complete dual verification. [t] requires the logged minutes. All of these are computable by D−4 only if the 221-flag review finishes. The go/no-go rule covers this.
- **Article type.** Practice of Epidemiology is stated (§3, §5.7). It passes.
- **Question.** "Can agentic checking be specified as a reusable, inspectable procedure?" is answered yes by the fact that the workflow exists. It is an aim, not a question. Move it to P5; keep the three sub-questions.

## 2. Literature claims

| v4 location | Problem | Fix |
|---|---|---|
| P4 gap sentence (mine) | **My error.** Zhang checked for "critical errors and unsoundness problems", not internal consistency. | "…large language model checks for internal inconsistencies or critical problems used a single prompt…" |
| P3 "single-prompt checks on the main document report useful flags" | "Useful" is not shown. Zhang's precision was judged by LLMs; La's "genuine" flags were mostly rounding. | "…reported flags judged genuine by unspecified manual review [La] or by LLM judges [Zhang]" |
| P3 "Journals require AI use to be fully described" | Flanagin is guidance for the JAMA Network only. | "*JAMA* Network journals require… [Flanagin 2026]"; add AJE's disclosure rule from its author guidelines |
| P2; Methods; gap sentence | Still [citation needed]: prevalence of inconsistencies, scrutiny of supplements, statcheck/GRIM, the meta-epidemiological guideline Lin named, an LLM-tool reporting guideline (TRIPOD-LLM? verify) | Fill these, and document the literature search behind "among the studies we identified" |

## 3. Remaining dissents

1. **Stability-rerun verification.** Candidates found only in a rerun will be unverified, and v4 does not budget their review. *Resolution:* report overlap and recovery of confirmed issues; list rerun-only candidates as unverified.
2. **The second operator is not independent.** Shiyin is the second reviewer. Running the pipeline on cohort packages before she verifies them exposes her to candidate sets. *Resolution:* she runs it on ExtraPapers packages, or does so after her verification is complete.
3. **"Reusable" in titles 1 and 2.** *Resolution:* say "publicly released" unless the second-operator run succeeds.
4. **Workload by D−4.** The schedule loads one student with the 221 dual reviews, the reruns, packaging, a corrections search and the Methods. *Resolution:* the go/no-go also requires calibration κ before the main review, with a stated minimum the group agrees on in advance.
5. **The period contrast.** I accept A's supplementary Newcombe risk difference; this one is closed.
6. **The provenance of Shiyin's gap.** v4's own caveat stands. Confirm her wording before the Introduction is written in her name.

## 4. The sentence a reviewer will quote back

> "The yield is not credited to its design (M8)… We did not compare the workflow with a single-prompt approach."

Set beside a title whose contribution is "a reusable multi-agent … workflow", this invites the question: *if the multi-agent design is not claimed to do anything, what does the paper contribute beyond a long prompt?*

The Discussion must answer this explicitly. The contribution is an auditable **specification** (inclusion rules, screening log, cards anchored to the source) plus an extraction-relevant yield measured on complete packages. It is not superiority over anything. If the group cannot write that paragraph without crediting the design, run the single-prompt baseline.
